{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE309nnn/GSE309864/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"species":["Mus musculus"],"gds_type":["Genome binding/occupancy profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309864"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Modulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation [ATAC-seq]","description":"The study investigates how MyoD1 dosage controls myogenic cell fate, employing bulk RNA-seq, ATAC-seq, and CUT&RUN. We determined genome-wide transcriptional, chromatin accessibility, and MyoD1 binding profiles in C2C12 myoblasts expressing endogenous Halo-tagged MyoD1 or doxycycline-inducible Halo–MyoD1, under growth and differentiation conditions with low or high MyoD1 dosage.","dates":{"publication":"2026/06/03"},"accession":"GSE309864","cross_references":{"GSM":["GSM9283709","GSM9283708","GSM9283707","GSM9283706","GSM9283701","GSM9283700","GSM9283710","GSM9283699","GSM9283698","GSM9283705","GSM9283704","GSM9283703","GSM9283702","GSM9283697","GSM9283696","GSM9283695"],"GPL":["24247"],"GSE":["309864"],"taxon":["Mus musculus"]}}